Venturepharm Laboratories Ltd, et al. – ‘SC 13D’ on 7/25/08 re: HedgePath Pharmaceuticals, Inc. – EX-2

On:  Friday, 7/25/08, at 6:21am ET   ·   Accession #:  1144204-8-41789   ·   File #:  5-51823

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

General Statement of Beneficial Ownership   —   Schedule 13D
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D      General Statement of Beneficial Ownership           HTML     67K 
 2: EX-1        Underwriting Agreement                              HTML      8K 
 3: EX-2        Plan of Acquisition, Reorganization, Arrangement,   HTML      7K 
                          Liquidation or Succession                              
 4: EX-3        Articles of Incorporation/Organization or By-Laws   HTML      6K 
 5: EX-4        Instrument Defining the Rights of Security Holders  HTML      6K 
 6: EX-5        Opinion re: Legality                                HTML      6K 

EX-2   —   Plan of Acquisition, Reorganization, Arrangement, Liquidation or Succession

This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]